Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States

por Sathyanarayanan, Vishwanath, Flowers, Christopher R., Iyer, Swaminathan P.
Publicado 2020

Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions

por Khan, Maliha, Samaniego, Felipe, Hagemeister, Fredrick B., Iyer, Swaminathan P.
Publicado 2021

Sustained response to erythropoietin for anemia in NK-cell large granular lymphocytosis: A brief case report

por Kwaramba, Tendai, Lewis, Brian, Burks, Bruce, Ruiz, Bernardo, Iyer, Swaminathan P., Safa, Firas
Publicado 2022

P1241: A NOVEL CEREBLON-BINDING MOLECULAR GLUE, SP-3164, SHOWS PRECLINICAL ACTIVITY IN NON-HODGKIN LYMPHOMAS

por Santiesteban, Daniela, Duncan, Aundrietta D., Mirza, Nadeem Q., Horrigan, Stephen, Dewitt, Sheila, Jacques, Vincent, Iyer, Swaminathan P.
Publicado 2023

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

por Anand, Kartik, Sahu, Geetanjali, Burns, Ethan, Ensor, Allyne, Ensor, Joe, Pingali, Sai Ravi, Subbiah, Vivek, Iyer, Swaminathan P
Publicado 2020

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment

por Duke, Taylor C., Nair, Ranjit, Torres-Cabala, Carlos, Amaria, Rodabe N., Keiser, Elizabeth, Miranda, Roberto, Iyer, Swaminathan P., Heberton, Meghan
Publicado 2020

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?

por Youssef, Jihad G., Zahiruddin, Faisal, Youssef, George, Padmanabhan, Sriram, Ensor, Joe, Pingali, Sai Ravi, Zu, Youli, Sahay, Sandeep, Iyer, Swaminathan P.
Publicado 2021

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

por Fiskus, Warren, Sharma, Sunil, Shah, Bhavin, Portier, Bryce P., Devaraj, Santhana G. T., Liu, Ka, Iyer, Swaminathan P., Bearss, David, Bhalla, Kapil N.
Publicado 2014

HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist

por Devaraj, Santhana G. T., Fiskus, Warren, Shah, Bhavin, Qi, Jun, Sun, Baohua, Iyer, Swaminathan P, Sharma, Sunil, Bradner, James E., Bhalla, Kapil N.
Publicado 2015

SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair

por Chakraborty, Sharmistha, Pandita, Raj K., Hambarde, Shashank, Mattoo, Abid R., Charaka, Vijaya, Ahmed, Kazi M., Iyer, Swaminathan P., Hunt, Clayton R., Pandita, Tej K.
Publicado 2018

Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse

por Nguyen, Christopher N., Iyer, Swaminathan P., Miranda, Roberto N., Torres-Cabala, Carlos A., Curry, Jonathan L., Fang, Penny, Thomas, Valencia D., Huen, Auris O.
Publicado 2021

BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified

por Marques-Piubelli, Mario L., Solis, Luisa M., Parra, Edwin R., Castillo, Luis Malpica, Gouni, Sushanth, Nair, Ranjit, Chihara, Dai, Konopleva, Marina, Wistuba, Ignacio I., Iyer, Swaminathan P., Vega, Francisco, Strati, Paolo
Publicado 2021

DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma

por Qiu, Lianqun, Tang, Guilin, Li, Shaoying, Vega, Francisco, Lin, Pei, Wang, Sa A., Wang, Wei, Iyer, Swaminathan P., Malpica, Luis, Miranda, Roberto N., Konoplev, Sergej, Tang, Zhenya, Fang, Hong, Medeiros, L. Jeffrey, Xu, Jie
Publicado 2022

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

por Huen, Auris, Haverkos, Bradley M., Zain, Jasmine, Radhakrishnan, Ramchandren, Lechowicz, Mary Jo, Devata, Sumana, Korman, Neil J., Pinter-Brown, Lauren, Oki, Yasuhiro, Barde, Prajak J., Nair, Ajit, Routhu, Kasi Viswanath, Viswanadha, Srikant, Vakkalanka, Swaroop, Iyer, Swaminathan P.
Publicado 2020

Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma

por Wu, Susan Y., Fang, Penny Q., Wang, Ethan B., Ahmed, Sairah, Duvic, Madeleine, Jain, Preetesh, Castillo, Luis E. Malpica, Nair, Ranjit, Steiner, Raphael E., Strati, Paolo, Huen, Auris O., Iyer, Swaminathan P., Pinnix, Chelsea C., Dabaja, Bouthaina S., Gunther, Jillian R.
Publicado 2023

Day 30 SUV(max) predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy

por Al Zaki, Ajlan, Feng, Lei, Watson, Grace, Ahmed, Sairah A., Mistry, Haleigh, Nastoupil, Loretta J., Hawkins, Misha, Nair, Ranjit, Iyer, Swaminathan P., Lee, Hun J., Steiner, Raphael E., Flowers, Christopher R., Shpall, Elizabeth J., Kebriaei, Partow, Neelapu, Sattva S., Westin, Jason R., Strati, Paolo
Publicado 2022

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

por Pinnix, Chelsea C., Gunther, Jillian R., Fang, Penny, Bankston, Mikaela E, Milgrom, Sarah A., Boyce, David, Lee, Hun Ju, Nair, Ranjit, Steiner, Raphael, Strati, Paolo, Ahmed, Sairah, Iyer, Swaminathan P., Westin, Jason, Parmar, Simrit, Rodriguez, M. Alma, Nastoupil, Loretta, Neelapu, Sattva, Flowers, Christopher, Dabaja, Bouthaina S.
Publicado 2020

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

por Jallouk, Andrew P., Gouni, Sushanth, Westin, Jason, Feng, Lei, Mistry, Haleigh, Steiner, Raphael E., James, Jinsu, Noorani, Mansoor, Horowitz, Sandra, Puebla-Osorio, Nahum, Fayad, Luis E., Iyer, Swaminathan P., Hawkins, Misha, Flowers, Christopher R., Ahmed, Sairah, Nastoupil, Lo retta J, Kebriaei, Partow, Shpall, Elizabeth J., Neelapu, Sattva S., Nieto, Yago, Strati, Paolo
Publicado 2022

Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement

por Akin, Serkan, Hosing, Chitra, Khouri, Issa, Ahmed, Sairah, Alousi, Amin, Fowler, Nathan, Joseph, Jacinth, Truxillo, Jonathan, Ramdial, Jeremy L., Maadani, Farzaneh, Rondon, Gabriela, Daher, May, Im, Jin S., Steiner, Raphael, Westin, Jason, Iyer, Swaminathan P., Dabaja, Bouthaina, Anderlini, Paolo, Popat, Uday R., Qazilbash, Muzaffar H., Flowers, Christopher R., Shpall, Elizabeth, Champlin, Richard E., Nieto, Yago, Srour, Samer A.
Publicado 2022

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

por Cherng, Hua-Jay J., Sun, Ryan, Sugg, Bryant, Irwin, Russell, Yang, Haopeng, Le, Cao Cuong, Deng, Qing, Fayad, Luis, Fowler, Nathan H., Parmar, Simrit, Steiner, Raphael, Hagemeister, Fredrick, Nair, Ranjit, Lee, Hun Ju, Rodriguez, Maria, Samaniego, Felipe, Iyer, Swaminathan P., Flowers, Christopher R., Wang, Linghua, Nastoupil, Loretta J., Neelapu, Sattva S., Ahmed, Sairah, Strati, Paolo, Green, Michael R., Westin, Jason
Publicado 2022